Status: Recruiting
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
This study intends to adopt standardized and rigorous cross-sectional research, collect biological specimens (including blood, feces, urine, saliva and tongue coating) from eligible subjects, and use liquid chromatography/mass spectrometry (LC-MS/MS) technology to explore early warning indicators of protein in patients with mild cognitive impairment and Alzheimer's disease
Participants needed: 650
Trial details
Age: 55+Biological sex: AllType: ObservationalSponsor: Guangzhou University of Traditional Chinese MedicineUpdated: Nov 15, 2022Locations: 1
Eligibility criteria
Older than 55-year-old，male or female. [+3]
Patients with acute cardiovascular and cerebrovascular diseases, acute infection... [+1]